Table 1 Baseline characteristics of the cohort of patients with MTBI and on OAT undergoing CT in the ED.
Patients, n (%) | 3054 (100) |
Age in years, median (IQR) | 83 (77-88) |
Sex, n (%) | |
Male | 1414 (46.3) |
Female | 1640 (53.7) |
Oral anticoagulant therapy, n (%) | |
DOACs | 1212 (39.7) |
VKA | 1842 (60.3) |
Reason for Oral anticoagulant therapy intake, n (%) | |
Atrial fibrillation | 2673 (87.5) |
Pulmonary embolism | 196 (6.4) |
Heart valves | 70 (2.3) |
Others | 115 (3.8) |
Mechanism of trauma, n (%) | |
Accidental falls | 2450 (80.2) |
Road incident | 155 (5.1) |
Syncope or epilepsy | 198 (13.0) |
Direct trauma | 51 (1.7) |
Outcome, n (%) | |
Global ICH | 290 (9.5) |
Immediate ICH | 253 (8.3) |
Delayed ICH | 37 (1.2) |
Neurosurgery or death at 30 days for ICH | 43 (1.4) |